Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis: A Randomized Clinical Trial

IMPORTANCE: Patients with cerebral venous thrombosis (CVT) are at risk of recurrent venous thrombotic events (VTEs). Non–vitamin K oral anticoagulants have not been evaluated in randomized controlled trials in CVT. OBJECTIVE: To compare the efficacy and safety of dabigatran etexilate with those of d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferro, José M., Coutinho, Jonathan M., Dentali, Francesco, Kobayashi, Adam, Alasheev, Andrey, Canhão, Patrícia, Karpov, Denis, Nagel, Simon, Posthuma, Laura, Roriz, José Mário, Caria, Jorge, Frässdorf, Mandy, Huisman, Holger, Reilly, Paul, Diener, Hans-Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724157/
https://www.ncbi.nlm.nih.gov/pubmed/31479105
http://dx.doi.org/10.1001/jamaneurol.2019.2764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724157/
https://www.ncbi.nlm.nih.gov/pubmed/31479105
http://dx.doi.org/10.1001/jamaneurol.2019.2764

Ejemplares similares